ConductScience.org, home
Oxbryta® Product Registry An Observational Study Designed to Evaluate the Effect of Oxbryta in Individuals With SCD
API referenceFor AI assistants

Trial · NCT04930445

Results by group523

Each measurement the trial posted, group by group, in the words and numbers it posted.

1 to 20 of 523

Download this page as JSON
OutcomeGroupCategoryValueSpreadUnits
Change in Hemoglobin From Pre-Oxbryta Treatment (Baseline) Through Month 60 Post-OxbrytaAll Participants3 months Post-Oxbryta0.5Standard Deviation 1.33Grams per deciliter (g/dL)
Change in Hemoglobin From Pre-Oxbryta Treatment (Baseline) Through Month 60 Post-OxbrytaAll Participants6 months Post-Oxbryta0.6Standard Deviation 1.47Grams per deciliter (g/dL)
Change in Hemoglobin From Pre-Oxbryta Treatment (Baseline) Through Month 60 Post-OxbrytaAll Participants9 months Post-Oxbryta0.5Standard Deviation 1.45Grams per deciliter (g/dL)
Change in Hemoglobin From Pre-Oxbryta Treatment (Baseline) Through Month 60 Post-OxbrytaAll Participants12 months Post-Oxbryta0.6Standard Deviation 1.36Grams per deciliter (g/dL)
Change in Hemoglobin From Pre-Oxbryta Treatment (Baseline) Through Month 60 Post-OxbrytaAll Participants18 months Post-Oxbryta0.7Standard Deviation 1.35Grams per deciliter (g/dL)
Change in Hemoglobin From Pre-Oxbryta Treatment (Baseline) Through Month 60 Post-OxbrytaAll Participants24 months Post-Oxbryta0.6Standard Deviation 1.46Grams per deciliter (g/dL)
Change in Hemoglobin From Pre-Oxbryta Treatment (Baseline) Through Month 60 Post-OxbrytaAll Participants30 months Post-Oxbryta0.5Standard Deviation 1.62Grams per deciliter (g/dL)
Change in Hemoglobin From Pre-Oxbryta Treatment (Baseline) Through Month 60 Post-OxbrytaAll Participants36 months Post-Oxbryta0.6Standard Deviation 1.62Grams per deciliter (g/dL)
Change in Hemoglobin From Pre-Oxbryta Treatment (Baseline) Through Month 60 Post-OxbrytaAll Participants42 months Post-Oxbryta0.4Standard Deviation 1.48Grams per deciliter (g/dL)
Change in Hemoglobin From Pre-Oxbryta Treatment (Baseline) Through Month 60 Post-OxbrytaAll Participants48 months Post-Oxbryta0.7Standard Deviation 1.47Grams per deciliter (g/dL)
Change in Hemoglobin From Pre-Oxbryta Treatment (Baseline) Through Month 60 Post-OxbrytaAll Participants54 months Post-Oxbryta0.1Standard Deviation 1.68Grams per deciliter (g/dL)
Change in Hemoglobin From Pre-Oxbryta Treatment (Baseline) Through Month 60 Post-OxbrytaAll Participants60 months Post-Oxbryta-0.2Standard Deviation 1.36Grams per deciliter (g/dL)
Change in Percent Reticulocyte Count From Pre-Oxbryta Treatment (Baseline) Through Month 60 Post-OxbrytaAll Participants3 months Post-Oxbryta-0.9Standard Deviation 5.50Percentage of reticulocytes
Change in Percent Reticulocyte Count From Pre-Oxbryta Treatment (Baseline) Through Month 60 Post-OxbrytaAll Participants6 months Post-Oxbryta-1.1Standard Deviation 6.01Percentage of reticulocytes
Change in Percent Reticulocyte Count From Pre-Oxbryta Treatment (Baseline) Through Month 60 Post-OxbrytaAll Participants9 months Post-Oxbryta-1.1Standard Deviation 5.97Percentage of reticulocytes
Change in Percent Reticulocyte Count From Pre-Oxbryta Treatment (Baseline) Through Month 60 Post-OxbrytaAll Participants12 months Post-Oxbryta-1.2Standard Deviation 6.34Percentage of reticulocytes
Change in Percent Reticulocyte Count From Pre-Oxbryta Treatment (Baseline) Through Month 60 Post-OxbrytaAll Participants18 months Post-Oxbryta-1.6Standard Deviation 6.69Percentage of reticulocytes
Change in Percent Reticulocyte Count From Pre-Oxbryta Treatment (Baseline) Through Month 60 Post-OxbrytaAll Participants24 months Post-Oxbryta-0.7Standard Deviation 6.32Percentage of reticulocytes
Change in Percent Reticulocyte Count From Pre-Oxbryta Treatment (Baseline) Through Month 60 Post-OxbrytaAll Participants30 months Post-Oxbryta-1.0Standard Deviation 6.92Percentage of reticulocytes
Change in Percent Reticulocyte Count From Pre-Oxbryta Treatment (Baseline) Through Month 60 Post-OxbrytaAll Participants36 months Post-Oxbryta-1.3Standard Deviation 7.04Percentage of reticulocytes

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04930445/results

API referenceFor AI assistants